Wikipedia

TMEM269

Transmembrane Protein 269 (TMEM269) is a protein which in humans is encoded by the TMEM269 gene.

TMEM269
Identifiers
AliasesTMEM269, transmembrane protein 269
External IDsMGI: 1922430 HomoloGene: 28290 GeneCards: TMEM269
Orthologs
SpeciesHumanMouse
Entrez

100129924

75180

Ensembl

ENSG00000274386

ENSMUSG00000028642

UniProt

A0A1B0GVZ9

Q9D4Y8

RefSeq (mRNA)

NM_001242750
NM_001354602

NM_029198

RefSeq (protein)

NP_001341531

NP_083474

Location (UCSC)Chr 1: 42.78 – 42.82 MbChr 4: 119.06 – 119.08 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Gene edit

The gene is located on the plus strand with a cytogenetic location of 1p34.2 and has the accession number A0A1B0GVZ9.1. The gene has a span of approximately 160,000 base pairs.[5] It has a divergent transcript expressed on the negative strand in the opposite direction of TMEM269.[6]

 

Transcript edit

RNA-seq data edit

 
Conceptually translated and annotated transcript of TMEM269 human mRNA

A study of RNA-seq data according to tissue type in humans found the expression of TMEM269 to be highest in the testes, brain, endometrium, and kidney.[7] The data indicates that TMEM269 is transcribed ubiquitously across tissue types at a fairly low rate with no tissue type with more than 0.4 reads per kilobase of transcript per million reads mapped. A separate study of RNA-seq data across tissue types indicated the highest expression for TMEM269 in the brain, the adrenal gland, and the testes[8]

Regulation of translation edit

A study of diabetic kidney disease (DKD) in mouse models determined that miRNA-181b-5b, an miRNA that is dramatically down-regulated in DKD mice, dramatically decreased the expression of TMEM269 (-4.52 fold difference or 22.12% total original expression, p-value <0.01).[9] A subsection of Table IIIa from the original study is included below with the values relevant to TMEM269. TMEM269 is one among 27 genes that had notably (4-fold difference) reduced expression of the genes tested; it ranked 18th for strongest effect among these genes.

TMEM269 was experimentally determined to be down-regulated by low phospholipid microdiets (Low-PL) in pelagic sole larvae when compared to high phospholipid microdiets (High-PL). TMEM269 was one among 15 identified differentially expressed transcripts according to Low-PL dietary exposure (among the group of 12 that were down-regulated).[10]

Protein edit

TMEM269 has two isoforms, with the more common variant being 245 amino acids in length. It has 5 transmembrane domains throughout the length of the protein and one large region similarity to the sequence of phosphatidylserine synthase. The two isoforms of TMEM269 have identical sequences apart from the second, less common, isoform having a deletion of the first 42 amino acids that are found in the first isoform's sequence.

 

Relative to other human proteins, TMEM269 is rich in methionine, serine, phenylalanine, and leucine, while it has a low percentage of glutamic acid, glutamine, and arginine.[11] The predicted molecular weight of TMEM269 is 26.9 kDa and the predicted isoelectric point is 6.7.[12]

 

Post Translation Modifications edit

There are four predicted sites of N-myristolyation (at amino acid positions 89–94, 102–107, 113–118, 137–142) for TMEM269.[13] N-Myristoylation may be involved in signal transduction, protein stability, and trafficking proteins to the membrane.[14] These N-myristolyation sites are predicted in various model organisms in addition to humans including mice, chickens, and zebrafish.

There are two predicted sites of O-linked glycosylation on the TMEM269 protein; this type of modification may regulate protein conformation, stability, and multimeric protein assembly.[15] These predictions are based on sites surpassing a 0.5 NetPhos threshold on a YinOYang post translational modification prediction algorithm[16] These sites are located at amino acid positions 35 and 125 on the protein.

Subcellular localization edit

Subcellular localization predictions indicate TMEM269 has the strongest likelihood of being located in the endoplasmic reticulum and the plasma membrane.[17] The Reinhardt's method for Cytplasmic/Nuclear discrimination predicts the human TMEM269 protein to be cytoplasmic with a reliability score of 94.1 [18]

Interactions edit

One study determined TMEM269 to be a candidate for non-promiscuous interaction with the protein Fam183b via yeast two-hybrid screening.[19] Fam183b has been characterized as essential for motile cilia in Xenopus but Fam183b loss-of-function studies have yielded no defects (in cilia or otherwise) in experiments using mice. TMEM269 was one of two proteins that were identified as having potential interaction with this protein.

Evolution edit

 
Multiple Sequence Alignment of TMEM269 Protein with Close Orthologs of Humans

TMEM269 is conserved in all jawed vertebrates but does not have orthologs in Cyclostomi, invertebrates, or non-animal life forms. Chondrichthyes or cartilaginous fish are the group of organisms that are most distantly related to humans that still have a TMEM269 ortholog. The approximate evolutionary date of divergence from Homo sapiens for most cartilaginous fish is estimated to be 464 million years ago. Based on information from sequences of the orthologs,[20] the human version of the protein shares an amino acid identity of around 50-60% with its most distant orthologs in fish and from 70 to 98% for closer orthologs in mammals (higher percentages for more closely related groups such as primates). TMEM269 does not have any clearly identifiable paralogs.

 

One measure of understanding the rate of evolution is determining how fast the sequence is diverging in comparison to other proteins. TMEM269 is diverging across orthologs at a moderate rate when compared to the quickly-diverging protein Fibrinogen Alpha Chain and the slowly-diverging protein Cytochrome C.

 
Corrected Sequence Divergence vs Estimated Date of Divergence in TMEM269, Cytochrome C, and Fibrinogen Alpha Chain.

 

References edit

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000274386 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000028642 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ National Center for Biotechnology Information (NCBI), TMEM269 gene page <https://www.ncbi.nlm.nih.gov/gene/100129924>
  6. ^ "TMEM269-DT". www.genecards.org. GeneCards The human ncRNA database.
  7. ^ Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. (February 2014). "Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics". Molecular & Cellular Proteomics. 13 (2): 397–406. doi:10.1074/mcp.M113.035600. PMC 3916642. PMID 24309898.
  8. ^ Khrebtukova, Irina. "Illumina Human Body Map 2.0 Project". NCBI. Illumina.
  9. ^ Hachero-Cruzado I, Rodriguez-Rua A, Torrent I, Roman-Padilla J and Manchado M (2020) Assessment of Growth, Lipid Metabolism and Gene Expression Responses in Senegalese Sole Larvae Fed With Low Dietary Phospholipid Levels. Front. Physiol. 11:572545. doi: 10.3389/fphys.2020.572545
  10. ^ Hachero-Cruzado I, Rodriguez-Rua A, Torrent I, Roman-Padilla J, Manchado M (2020). "Assessment of Growth, Lipid Metabolism and Gene Expression Responses in Senegalese Sole Larvae Fed With Low Dietary Phospholipid Levels". Frontiers in Physiology. 11: 572545. doi:10.3389/fphys.2020.572545. PMC 7569605. PMID 33123028.
  11. ^ Brendel V, Bucher P, Nourbakhsh IR, Blaisdell BE, Karlin S (March 1992). "Methods and algorithms for statistical analysis of protein sequences". Proceedings of the National Academy of Sciences of the United States of America. 89 (6). Proc. Natl. Acad. Sci. USA 89(6):2002-6 PubMed: 1549558: 2002–2006. Bibcode:1992PNAS...89.2002B. doi:10.1073/pnas.89.6.2002. PMC 48584. PMID 1549558.
  12. ^ "ExPASy pI prediction tool". Expasy.[permanent dead link]
  13. ^ "Motif Scan Results of TMEM269". myhits.sib.swiss. Motif Scan.
  14. ^ Wang B, Dai T, Sun W, Wei Y, Ren J, Zhang L, et al. (April 2021). "Protein N-myristoylation: functions and mechanisms in control of innate immunity". Cellular & Molecular Immunology. 18 (4): 878–888. doi:10.1038/s41423-021-00663-2. PMC 7966921. PMID 33731917.
  15. ^ Bektas M, Rubenstein DS (July 2011). "The role of intracellular protein O-glycosylation in cell adhesion and disease". Journal of Biomedical Research. 25 (4). NCBI: 227–236. doi:10.1016/S1674-8301(11)60031-6. PMC 3597071. PMID 23554695.
  16. ^ Gupta, R.; Brunak, S. "Prediction of glycosylation sites in proteomes: from post-translational modifications to protein function". DTU Health Tech. Pacific Symposium on Biocomputing.
  17. ^ "PSORT II TMEM269 Results". PSORT II Prediction Tool.[permanent dead link]
  18. ^ Reinhardt A, Hubbard T (May 1998). "Using neural networks for prediction of the subcellular location of proteins". Nucleic Acids Research. 26 (9): 2230–2236. doi:10.1093/nar/26.9.2230. PMC 147531. PMID 9547285.
  19. ^ Beckers, A., Ott, T., Schuster-Gossler, K. et al. The evolutionary conserved FOXJ1 target gene Fam183b is essential for motile cilia in Xenopus but dispensable for ciliary function in mice. Sci Rep 8, 14678 (2018). https://doi.org/10.1038/s41598-018-33045-2
  20. ^ "Protein BLAST: search protein databases using a protein query". blast.ncbi.nlm.nih.gov. NCBI.
Retrieved from "https://en.wikipedia.org/w/index.php?title=TMEM269&oldid=1219284608"